A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-08-21) →
What happened
HLB Therapeutics disclosed convertible bonds to raise US$7.86M, about 4.2% of its market value.
For context, this raise equals about 4.2% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$7.86M |
| vs. market value | 4.2% |
| Filed | 2026-08-07, Material event report (rights offering) |
| Source | DART rcept 20260807000004 → open original filing |
Versions of this filing
- 2026-08-07Original (this page)
- 2026-08-21Amendment 1
Source: DART. Information only, not investment advice.